The Effects of Statin Dose, Lipophilicity, and Combination of Statins plus Ezetimibe on Circulating Oxidized Low-Density Lipoprotein Levels: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

• Egile Nagusiak: Tannaz Jamialahmadi (Egilea), Fatemeh Baratzadeh (Egilea), Željko Reiner (Egilea), Luis E. Simental-Mendía (Egilea), Suowen Xu (Egilea), Andrey V. Susekov (Egilea), Raul D. Santos (Egilea), Amirhossein Sahebkar (Egilea)
• Formatua: Liburua
• Argitaratua: Hindawi Limited, 2021-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background. Elevated plasma low-density lipoprotein cholesterol (LDL-C) is the main risk factor for atherosclerotic cardiovascular disease (ASCVD). Statins are the drugs of choice for decreasing LDL-C and are used for the prevention and management of ASCVD. Guidelines recommend that subjects with hi...